Literature DB >> 5289865

Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs.

A S Horn, S H Snyder.   

Abstract

Phenothiazines and butyrophenones are known to alter dopamine (3,4-dihydroxyphenethylamine) metabolism in the brain in a fashion suggesting that they may block dopamine receptors. We observed, using Dreiding molecular models, that dopamine in its solid-state conformation is superimposable upon a portion of the known x-ray structure of chlorpromazine [2-chloro-10-(3-dimethylaminopropyl)-phenothiazine]. The ability of phenothiazine drugs to mimic the dopamine-like conformation correlates with their antischizophrenic efficacy. These structure-activity relationships explain the importance of a substituent in ring a, a three-carbon side chain bearing the amino group, and a hetero atom between rings a and c.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289865      PMCID: PMC389413          DOI: 10.1073/pnas.68.10.2325

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

2.  Inhibition by chlorpromazine of the effects of dopamine on the dog kidney.

Authors:  G Brotzu
Journal:  J Pharm Pharmacol       Date:  1970-09       Impact factor: 3.765

3.  Activity correlations and the mode of action of aminoalkylphenothiazine tranquillizers.

Authors:  A L Green
Journal:  J Pharm Pharmacol       Date:  1967-03       Impact factor: 3.765

4.  The structure of the catecholamines. I. The crystal structure of noradrenaline hydrochloride.

Authors:  D Carlström; R Bergin
Journal:  Acta Crystallogr       Date:  1967-08-10

5.  Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.

Authors:  P A Janssen; C J Niemegeers; K H Schellekens; F M Lenaerts
Journal:  Arzneimittelforschung       Date:  1967-07

6.  Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.

Authors:  H Nybäck; G Sedvall
Journal:  J Pharmacol Exp Ther       Date:  1968-08       Impact factor: 4.030

7.  The preferred conformation of dopamine from molecular orbital theory.

Authors:  L B Kier; E B Truitt
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

Review 8.  Efficacy of tranquilizing and antidepressant drugs.

Authors:  J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

9.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

10.  Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

Authors:  B K Yeh; J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

View more
  23 in total

1.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  The role of dopamine in the antipsychotic effect and the pathogenesis of schizophrenia.

Authors:  T J Crow; E C Johnstone; A Longden; F Owen; G Riley
Journal:  Proc R Soc Med       Date:  1977

3.  Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings.

Authors:  Thomas W Weickert; Terry E Goldberg; Michael F Egan; Jose A Apud; Martijn Meeter; Catherine E Myers; Mark A Gluck; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

4.  The biochemical evaluation of psychotropic drugs.

Authors:  A V Mackay
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

5.  The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.

Authors:  R Dunstan; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

6.  Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

7.  Dopamine receptor blockade by neuroleptic drugs in Aplysia neurones.

Authors:  W D Heiss; J Hoyer
Journal:  Experientia       Date:  1974-11-15

8.  Penile parkinsonism.

Authors:  M P Osborne
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

9.  On the antagonism of ergot alkaloids and dopamine by phenothiazines.

Authors:  T W Stone
Journal:  Experientia       Date:  1974-07-15

10.  Effect of centrally active drugs on dopamine oxidation by rat brain catecholamine oxidase.

Authors:  R A Løvstad
Journal:  Experientia       Date:  1979-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.